Tin tức & Cập nhật
Lọc theo Chuyên ngành:

WAYFINDER updates boost tezepelumab role in OCS-dependent severe asthma
03 Jun 2025
bởiAudrey Abella
Updated results from the open-label, phase IIIb WAYFINDER study continue to support the oral corticosteroid (OCS)-sparing efficacy of tezepelumab in the treatment of patients with OCS-dependent severe asthma.